S100A6 and ductal breast carcinoma in situ: We chose S100A6 and S100B from the family because of over expression of S100A6 at the protein level in both MCF7 and DCIS cells and S100B as one marker discovered in RNA sequencing of MCF7 cells and the proteomics of DCIS.